These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 20537521)

  • 41. Post-transplant early recurrent proteinuria in patients with focal glomerulosclerosis--angiotensin II immunostaining and treatment outcome.
    Mizuiri S; Kawamura T; Miyagi M; Arai K; Sakai K; Aikawa A; Ohara T; Shibuya K; Ishikawa Y; Kawamura S; Hasegawa A
    Clin Transplant; 2005; 19 Suppl 14():12-9. PubMed ID: 15955164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pediatric focal segmental glomerulosclerosis: favorable transplantation outcome with plasma exchange.
    Fadel FI; Bazaraa HM; Abdel Mawla MA; Salah DM
    Ital J Pediatr; 2021 Dec; 47(1):236. PubMed ID: 34906202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rituximab for post-transplant recurrences of FSGS.
    Bayrakci US; Baskin E; Sakalli H; Karakayali H; Haberal M
    Pediatr Transplant; 2009 Mar; 13(2):240-3. PubMed ID: 18822107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation.
    Audard V; Kamar N; Sahali D; Cardeau-Desangles I; Homs S; Remy P; Aouizerate J; Matignon M; Rostaing L; Lang P; Grimbert P
    Transpl Int; 2012 May; 25(5):e62-6. PubMed ID: 22409658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.
    Savin VJ; Sharma R; Sharma M; McCarthy ET; Swan SK; Ellis E; Lovell H; Warady B; Gunwar S; Chonko AM; Artero M; Vincenti F
    N Engl J Med; 1996 Apr; 334(14):878-83. PubMed ID: 8596570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: A systematic review and meta-analysis of 77 case-reports and case-series.
    Kashgary A; Sontrop JM; Li L; Al-Jaishi AA; Habibullah ZN; Alsolaimani R; Clark WF
    BMC Nephrol; 2016 Jul; 17(1):104. PubMed ID: 27473582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Focal segmental glomerulosclerosis].
    Yuzawa Y; Matsuo S
    Nihon Rinsho; 2004 Oct; 62(10):1837-41. PubMed ID: 15500127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis.
    Boardman R; Trofe J; Alloway R; Rogers C; Roy-Chaudhury P; Cardi M; Safdar S; Groene B; Buell J; Hanaway M; Thomas M; Alexander W; Munda R; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):817-8. PubMed ID: 15848542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review.
    Naciri Bennani H; Bonzi JY; Noble J; Terrec F; Motte L; Imerzoukene F; Bugnazet M; Giovannini D; Janbon B; Malvezzi P; Rostaing L; Jouve T
    Blood Purif; 2020; 49(3):322-333. PubMed ID: 31913143
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP; van de Kar NC; Wetzels JF
    Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation.
    Fujisawa M; Iijima K; Ishimura T; Higuchi A; Isotani S; Yoshiya K; Arakawa S; Hamami G; Matsumoto O; Yoshikawa N; Kamidono S
    Pediatr Nephrol; 2002 Mar; 17(3):165-8. PubMed ID: 11956852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis.
    Meyer TN; Thaiss F; Stahl RA
    Transpl Int; 2007 Dec; 20(12):1066-71. PubMed ID: 17887957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term plasmapheresis and protein A column treatment of recurrent FSGS.
    Belson A; Yorgin PD; Al-Uzri AY; Salvatierra O; Higgins J; Alexander SR
    Pediatr Nephrol; 2001 Dec; 16(12):985-9. PubMed ID: 11793085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients.
    Matalon A; Markowitz GS; Joseph RE; Cohen DJ; Saal SD; Kaplan B; D'Agati VD; Appel GB
    Clin Nephrol; 2001 Oct; 56(4):271-8. PubMed ID: 11680656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome of kidney allograft in patients with adulthood-onset focal segmental glomerulosclerosis: comparison with childhood-onset FSGS.
    Hwang JH; Han SS; Huh W; Park SK; Joo DJ; Kim MS; Kim YS; Min SI; Ha J; Kim SJ; Kim S; Kim YS
    Nephrol Dial Transplant; 2012 Jun; 27(6):2559-65. PubMed ID: 22187318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rituximab for Recurrence of Primary Focal Segmental Glomerulosclerosis After Kidney Transplantation: Clinical Outcomes.
    Garrouste C; Canaud G; Büchler M; Rivalan J; Colosio C; Martinez F; Aniort J; Dudreuilh C; Pereira B; Caillard S; Philipponnet C; Anglicheau D; Heng AE
    Transplantation; 2017 Mar; 101(3):649-656. PubMed ID: 27043407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination of High-Dose Intravenous Cyclosporine and Plasma Exchange Treatment Is Effective in Post-Transplant Recurrent Focal Segmental Glomerulosclerosis: Results of Case Series.
    Demir ME; Uyar M; Merhametsiz O
    Transplant Proc; 2020 Apr; 52(3):843-849. PubMed ID: 32199645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Post-Transplant Recurrence of Focal Segmental Glomerulosclerosis in a Child With Heterozygous Mutations in NPHS1 and NPHS2.
    Battelino N; Arnol M; Kandus A; Ponikvar R; Novljan G
    Ther Apher Dial; 2016 Jun; 20(3):312-7. PubMed ID: 27312921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Focal segmental glomerulosclerosis recurrence in the renal allograft.
    Leca N
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):448-52. PubMed ID: 25168835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation.
    Staeck O; Slowinski T; Lieker I; Wu K; Rudolph B; Schmidt D; Brakemeier S; Neumayer HH; Wei C; Reiser J; Budde K; Halleck F; Khadzhynov D
    Transplantation; 2015 Dec; 99(12):2593-7. PubMed ID: 26371597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.